Spinelli Letizia, Stabile Eugenio, Giugliano Giuseppe, Morisco Carmine, Giudice Caterina Anna, Imbriaco Massimo, Santoro Mario, Esposito Giovanni, Trimarco Bruno
Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.
Department of Translational Medical Sciences, Federico II University, Naples, Italy.
Int J Cardiovasc Imaging. 2018 Feb;34(2):201-210. doi: 10.1007/s10554-017-1221-0. Epub 2017 Aug 1.
Intramyocardial dissecting hematoma is an uncommon complication of myocardial infarction potentially leading to cardiac rupture. The aim of the present study was to investigate coronary reperfusion results, left ventricular (LV) function recovery and remodeling and clinical outcomes in patients with anterior STEMI complicated by intramyocardial hematoma. We prospectively studied 87 patients (mean age 59 ± 10 years; 88% male) with anterior STEMI (42 with intramyocardial hematoma) in order to evaluate coronary reperfusion results, LV remodeling (≥15% increase in end-systolic volume) and clinical outcomes (cardiac death, non-fatal reinfarction, and hospitalization for congestive heart failure) at 24 months. Thrombolysis in myocardial infarction (TIMI) flow score and myocardial blush grade (MBG) were assessed both pre- and post-percutaneous coronary intervention (PCI) and speckle-tracking echocardiography was performed post PCI and at 6-month follow-up. Patients with hematoma had lower post-PCI TIMI score and MBG, higher heart rate, worse LV ejection fraction and longitudinal or rotational function than their counterparts. LV remodeling occurred in 33 (78.6%) patients with hematoma and 11 (24.4%) patients without (p < 0.001). Independent predictors of LV remodeling were heart rate (p = 0.018), MBG (p = 0.036) and presence of hematoma (p < 0.001). Hematoma (log-rank test, χ = 9.849; p = 0.002) and LV remodeling (log-rank test, χ = 13.770; p < 0.001) were associated to a higher rate of adverse events. Cox analysis identified LV remodeling as the only independent predictor of adverse events (hazard ratio = 3.912; 95% confidence interval, 1.429-10.714; p = 0.008). Intramyocardial dissecting hematoma complicating anterior STEMI is an independent determinant of LV remodeling and is associated to poor prognosis.
心肌内夹层血肿是心肌梗死的一种罕见并发症,可能导致心脏破裂。本研究的目的是调查前壁ST段抬高型心肌梗死(STEMI)合并心肌内血肿患者的冠状动脉再灌注结果、左心室(LV)功能恢复与重塑以及临床结局。我们前瞻性研究了87例前壁STEMI患者(平均年龄59±10岁;88%为男性),其中42例合并心肌内血肿,以评估24个月时的冠状动脉再灌注结果、左心室重塑(收缩末期容积增加≥15%)以及临床结局(心源性死亡、非致死性再梗死和因充血性心力衰竭住院)。在经皮冠状动脉介入治疗(PCI)前后评估心肌梗死溶栓(TIMI)血流分级和心肌灌注分级(MBG),并在PCI后及6个月随访时进行斑点追踪超声心动图检查。与无血肿患者相比,有血肿患者PCI后的TIMI分级和MBG较低,心率较高,左心室射血分数及纵向或旋转功能较差。33例(78.6%)有血肿患者和11例(24.4%)无血肿患者发生左心室重塑(p<0.001)。左心室重塑的独立预测因素为心率(p=0.018)、MBG(p=0.036)和血肿的存在(p<0.001)。血肿(对数秩检验,χ=9.849;p=0.002)和左心室重塑(对数秩检验,χ=13.770;p<0.001)与较高的不良事件发生率相关。Cox分析确定左心室重塑是不良事件的唯一独立预测因素(风险比=3.912;95%置信区间,1.429-10.714;p=0.008)。前壁STEMI合并心肌内夹层血肿是左心室重塑的独立决定因素,且与预后不良相关。